Found 8 matching trials
The Iguratimod Effect on Lupus Nephritis (IGeLU) PHASE2 This study is a 52-week, randomized, open, active-controlled trial of patie...
Show More Learn More & Join Trial
To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom PHASE4 30 untreated IgG4 related disease (IgG4-RD) patients with mild symptom are ...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Iguratimod as Treatment for Refractory Lupus Nephritis NA This study is to evaluate the efficacy and safety of a novel chemical synth...
Show More Learn More & Join Trial
The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment PHASE4 This study is designed to observed prospectively the efficacy and safety of...
Show More Learn More & Join Trial
Study of Iguratimod in Sjögren's Syndrome PHASE1 A single-center, self-control, open-label study of efficacy and safety of I...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate PHASE3 The purpose of this study is to evaluate the efficacy and safety of T-614 v...
Show More Location
Multiple Locations
Learn More & Join Trial
The Clinical Efficacy of Immunomodulators in RA Patients PHASE4 This study includes naive patients and csDMARDs-IR RA patients, treated wit...
Show More Learn More & Join Trial
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA PHASE4 RA is a common autoimmune disease that causes joint damage.It is necessary ...
Show More Learn More & Join Trial